LISSET JARQUIN: Open Payments
NPI 1396429221 · RESTON, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,058 in 45 payments from 20 companies in 2025. Trend: 2023 $304 · 2024 $2,562 · 2025 $1,058
Food & beverage: $1,058
| Company | Payments | Amount |
|---|---|---|
| Sumitomo Pharma America, Inc. | 7 | $164 |
| PROGENICS PHARMACEUTICALS, INC. | 4 | $104 |
| Ferring Pharmaceuticals Inc. | 4 | $91 |
| Janssen Biotech, Inc. | 3 | $84 |
| TOLMAR, INC. | 3 | $82 |
| PFIZER INC. | 3 | $68 |
| Merck Sharp & Dohme LLC | 3 | $60 |
| Antares Pharma, Inc. | 2 | $49 |
| Boston Scientific Corporation | 2 | $47 |
| ABBVIE INC. | 2 | $46 |
Products named: GEMTESA, XTANDI, PYLARIFY, ADSTILADRIN, ERLEADA, JATENZO, XYOSTED, Axonics.
Industry payments across VA — which companies pay providers there.
